Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients

Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients

Akiko Yamamoto,1 Annabelle A Okada,1 Atsuhiko Sugitani,1,2 Daisuke Kunita,1 Tosho Rii,1 Reiji Yokota1 1Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan; 2Department of Ophthalmology, Kugayama Hospital, Tokyo, Japan Purpose: To describe outcomes of intravitreal ranibizu...

Full description

Bibliographic Details
Main Authors: Yamamoto A, Okada AA, Sugitani A, Kunita D, Rii T, Yokota R
Format: Article
Language:English
Published: Dove Medical Press 2013-04-01
Series:Clinical Ophthalmology
Online Access:http://www.dovepress.com/two-year-outcomes-of-pro-re-nata-ranibizumab-monotherapy-for-exudative-a12822

Similar Items

Similar Items